Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
about
Pharmacology and rationale for imatinib in the treatment of sclerodermaTrends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesSex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwidePrevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.Sex differences in patients with systemic lupus erythematosus from Northwest Spain.Mortality in systemic sclerosis-a single centre study from the UK.Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseasesSwift and Complete Healing of Digital Ulcers after Macitentan Treatment.Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.Deciphering the genetic background of systemic sclerosis.The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies.Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review.MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.Early morphologic and functional changes of atherosclerosis in systemic sclerosis-a systematic review and meta-analysis.Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients.Social/economic costs and health-related quality of life in patients with scleroderma in Europe.Mortality in the Waikato Hospital Systemic Sclerosis Cohort.Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain.Distinct mortality profile in systemic sclerosis: a death certificate study in Rio de Janeiro, Brazil (2006-2015) using a multiple causes of death analysis.Social/economic costs and health-related quality of life in patients with rare diseases in Europe.Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.
P2860
Q26825153-77C57B10-C261-41C4-A12C-09B26B0B9C16Q26864958-887668CA-2928-4339-96DC-CBF9115F6357Q30251721-047A46B3-81D4-4A64-9530-802B242D3425Q30658087-8A31092D-68AB-4FDA-83F7-98502232319DQ33408763-DC693F50-12FB-451C-BB68-D5FDA1FB024CQ34653727-1806F373-5682-4AF3-B72A-E994616A3509Q34979110-6868EEB3-C604-42EC-8D85-67CFF3440BB9Q35283742-49A35AC9-C00F-4E51-BA1C-C16A1670A24FQ36193496-E94FF8D1-EC55-4AA0-9F09-7A35EB02611BQ37413166-E22E2688-ED62-457A-BA0D-623431D43DF8Q37438934-007CC431-D99A-4999-B7AB-E3EC4CDD6F07Q37475563-41BEFF5E-4E63-436A-ACCA-88F0A40B37F8Q37605794-94F20C83-4910-48D7-9A93-828DFBC6885CQ37905783-93468909-ACD6-4593-996A-ADB18A95BA1FQ37973712-1403EEEE-73C1-49FB-9DEA-E7058C7EE94EQ38015065-B13E2910-AFA1-4AC0-AFE6-17AC915A8673Q38654746-F50DA96C-2C67-422D-905D-5703D7403BF9Q38937968-EA21B097-7A8F-48C7-BE3B-443E517BBEEBQ39035482-0D494332-C86C-48A7-8328-D35B380C2382Q39366363-4D14D48E-507A-4861-B298-5E3358A22049Q39869191-6D563472-D09F-4B91-BE96-DBE7C5520103Q40173071-41E4433A-EC17-4275-89A1-1E8F40F7F5BBQ40696023-4FFC48CB-846A-4384-B4CC-CC833BEFBC24Q40809160-A611CE5A-2DA4-4143-9D30-2AD5407059BBQ40813743-5E5C94A8-3909-49DD-9226-CA87438D13C4Q44445656-69D0AC8C-EA4F-4119-8B0D-8DBFAB74E0C2Q47678850-DEE5386E-B075-4266-AF0E-254BC7CCF76DQ47787703-C6FF7719-4489-4F46-87B2-E2E7CECB8C01Q51160191-E52DEBEC-5893-467B-BF67-8A2C4E26C612
P2860
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@en
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@nl
type
label
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@en
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@nl
prefLabel
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@en
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@nl
P2093
P1433
P1476
Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study.
@en
P2093
Carlos Gonzalez-Juanatey
Javier Llorca
Jose A Miranda-Filloy
Maria C Arias-Nuñez
Miguel A Gonzalez-Gay
Tomas R Vazquez-Rodriguez
P304
P356
10.1097/MD.0B013E318189372F
P407
P577
2008-09-01T00:00:00Z